Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.24+0.01 (+3.94%)
Close on Nov 18, 2026Market cap $3.73MP/E –Yield –
Traws Pharma operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Traws Pharma's operating income for the twelve months ending Jun 30, 2026 was -$21.54M. For fiscal 2025 it was -$17.88M. The highest annual figure on record is -$16.50M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.88M | – |
| FY2024 | Dec 31, 2024 | -$142.37M | – |
| FY2023 | Dec 31, 2023 | -$20.30M | – |
| FY2022 | Dec 31, 2022 | -$19.63M | – |
| FY2021 | Dec 31, 2021 | -$16.50M | – |
| FY2020 | Dec 31, 2020 | -$24.99M | – |
| FY2019 | Dec 31, 2019 | -$21.70M | – |
| FY2018 | Dec 31, 2018 | -$23.28M | – |
| FY2017 | Dec 31, 2017 | -$25.74M | – |
| FY2016 | Dec 31, 2016 | -$23.70M | – |
| FY2015 | Dec 31, 2015 | -$23.97M | – |
| FY2014 | Dec 31, 2014 | -$63.74M | – |
| FY2013 | Dec 31, 2013 | -$62.22M | – |
| FY2012 | Dec 31, 2012 | -$22.28M | – |
| FY2011 | Dec 31, 2011 | -$27.57M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.18M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.95M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.37M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.06M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.25M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.28M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.54M | – |
| Q2 FY2024 | Jun 30, 2024 | -$123.35M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.21M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.46M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.09M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.61M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.14M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.73M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.64M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.12M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.13M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.76M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.99M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.65M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.10M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.26M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.27M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.34M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.13M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.73M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.10M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.63M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.24M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.15M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.59M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.64M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.90M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.12M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.76M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.07M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.79M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.47M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.32M | – |
See a number that looks wrong?